Format
Sort by
Items per page

Send to

Choose Destination

Best matches for fraxe parkinson's:

Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease. Costa A et al. Parkinsonism Relat Disord. (2011)

A service development study of the assessment and management of fracture risk in Parkinson's disease. Shribman S et al. J Neurol. (2014)

Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Niu YQ et al. Parkinsonism Relat Disord. (2014)

Search results

Items: 1 to 20 of 80

1.

Role of miRNAs in development and disease: Lessons learnt from small organisms.

Chandra S, Vimal D, Sharma D, Rai V, Gupta SC, Chowdhuri DK.

Life Sci. 2017 Sep 15;185:8-14. doi: 10.1016/j.lfs.2017.07.017. Epub 2017 Jul 17. Review.

PMID:
28728902
2.

Habituation is altered in neuropsychiatric disorders-A comprehensive review with recommendations for experimental design and analysis.

McDiarmid TA, Bernardos AC, Rankin CH.

Neurosci Biobehav Rev. 2017 Sep;80:286-305. doi: 10.1016/j.neubiorev.2017.05.028. Epub 2017 Jun 1. Review.

PMID:
28579490
3.

Stem Cell Technology for (Epi)genetic Brain Disorders.

Riemens RJM, Soares ES, Esteller M, Delgado-Morales R.

Adv Exp Med Biol. 2017;978:443-475. doi: 10.1007/978-3-319-53889-1_23. Review.

PMID:
28523560
4.

mGlu5 negative allosteric modulators: a patent review (2013 - 2016).

Emmitte KA.

Expert Opin Ther Pat. 2017 Jun;27(6):691-706. doi: 10.1080/13543776.2017.1280466. Epub 2017 Jan 19. Review.

PMID:
28067079
5.

Molecular neurobiology of mTOR.

Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J.

Neuroscience. 2017 Jan 26;341:112-153. doi: 10.1016/j.neuroscience.2016.11.017. Epub 2016 Nov 23. Review.

6.

[Glutamate Metabotropic Receptors: Structure, Localisation, Functions].

Perfilova VN, Tyurenkov IN.

Usp Fiziol Nauk. 2016 Apr-Jun;47(2):98-112. Review. Russian.

PMID:
27530046
7.

Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Robertson EE, Hall DA, McAsey AR, O'Keefe JA.

Clin Neuropsychol. 2016 Aug;30(6):849-900. doi: 10.1080/13854046.2016.1202239. Review.

PMID:
27414076
8.

The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis.

Riva P, Ratti A, Venturin M.

Curr Alzheimer Res. 2016;13(11):1219-1231. Review.

9.

Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function.

Kamceva M, Benedict J, Nairn AC, Lombroso PJ.

Neural Plast. 2016;2016:8136925. doi: 10.1155/2016/8136925. Epub 2016 Apr 12. Review.

10.

ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.

Cozaru GC, Aşchie M, Mitroi AF, Poinăreanu I, Gorduza EV.

Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):15-22.

PMID:
27125067
11.

Epigenetic Basis of Neuronal and Synaptic Plasticity.

Karpova NN, Sales AJ, Joca SR.

Curr Top Med Chem. 2017;17(7):771-793. Review.

PMID:
27086781
12.

A single case report of MR-guided focused ultrasound thalamotomy for tremor in fragile X-associated tremor/ataxia.

Cerquera C, Rumià J, Herrera JM, Moreno V, Bargalló N, Valldeoriola F.

Parkinsonism Relat Disord. 2016 Jul;28:159-60. doi: 10.1016/j.parkreldis.2016.04.002. Epub 2016 Apr 4. No abstract available.

PMID:
27066991
13.

Mouse Genetic Models of Human Brain Disorders.

Leung C, Jia Z.

Front Genet. 2016 Mar 23;7:40. doi: 10.3389/fgene.2016.00040. eCollection 2016. Review.

14.

[Scans without Evidence of Dopamine Deficit (SWEDDs)].

Mukai Y, Murata M.

Brain Nerve. 2016 Jan;68(1):73-81. doi: 10.11477/mf.1416200350. Review. Japanese.

PMID:
26764301
15.

Induced pluripotent stem cells for modeling neurological disorders.

Russo FB, Cugola FR, Fernandes IR, Pignatari GC, Beltrão-Braga PC.

World J Transplant. 2015 Dec 24;5(4):209-21. doi: 10.5500/wjt.v5.i4.209. Review.

16.

VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.

Nickols HH, Yuh JP, Gregory KJ, Morrison RD, Bates BS, Stauffer SR, Emmitte KA, Bubser M, Peng W, Nedelcovych MT, Thompson A, Lv X, Xiang Z, Daniels JS, Niswender CM, Lindsley CW, Jones CK, Conn PJ.

J Pharmacol Exp Ther. 2016 Jan;356(1):123-36. doi: 10.1124/jpet.115.226597. Epub 2015 Oct 26.

17.

G-quadruplexes: Emerging roles in neurodegenerative diseases and the non-coding transcriptome.

Simone R, Fratta P, Neidle S, Parkinson GN, Isaacs AM.

FEBS Lett. 2015 Jun 22;589(14):1653-68. doi: 10.1016/j.febslet.2015.05.003. Epub 2015 May 13. Review.

18.

Metabotropic Glutamate Receptors in Central Nervous System Diseases.

Golubeva AV, Moloney RD, O'Connor RM, Dinan TG, Cryan JF.

Curr Drug Targets. 2016;17(5):538-616. Review.

PMID:
25777273
19.

Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.

Jaeschke G, Kolczewski S, Spooren W, Vieira E, Bitter-Stoll N, Boissin P, Borroni E, Büttelmann B, Ceccarelli S, Clemann N, David B, Funk C, Guba W, Harrison A, Hartung T, Honer M, Huwyler J, Kuratli M, Niederhauser U, Pähler A, Peters JU, Petersen A, Prinssen E, Ricci A, Rueher D, Rueher M, Schneider M, Spurr P, Stoll T, Tännler D, Wichmann J, Porter RH, Wettstein JG, Lindemann L.

J Med Chem. 2015 Feb 12;58(3):1358-71. doi: 10.1021/jm501642c. Epub 2015 Feb 2.

PMID:
25565255
20.

Metabotropic glutamate receptors as drug targets: what's new?

Nicoletti F, Bruno V, Ngomba RT, Gradini R, Battaglia G.

Curr Opin Pharmacol. 2015 Feb;20:89-94. doi: 10.1016/j.coph.2014.12.002. Epub 2014 Dec 12. Review.

PMID:
25506748

Supplemental Content

Loading ...
Support Center